Ainos Corporation (AIMD) - Long-Term Liabilities to Capital

Ainos Corporation - graphic logo of issuer AIMD

The long-term debt-to-equity ratio illustrates the debt obligations of Ainos, Inc. (AIMD), with 0.00 representing the latest level. The company is implementing AI systems for the instantaneous decoding of biological samples to minimize human error. Patents for rapid breath tests ensure business resilience, despite slow adoption. Operational efficiency is being enhanced through cloud IT outsourcing and the contract manufacturing of diagnostic systems.

Ainos - AIMD Long-Term Debt to Capital (period 04/28/2023 - 10/31/2026)
Product sample of Ainos, Inc.

This ratio measures the proportion of long-term liabilities within the equity structure, determining financial stability during revenue contractions. For Ainos, Inc. (AIMD), this is critical, as the slow commercialization of AI diagnostics requires stable funding. By analyzing the long-term debt-to-equity ratio on GURU.Markets, an investor can see the balance between debt-driven growth and default risk. Low values confirm a conservative approach to capital, characterizing the company's assets as low-risk.

Competing companies

Long-Term Debt to Equity Ratio Agilent Technologies, Inc. (A)|Long-Term Debt to Capital DGX|ILMN - Long-Term Liabilities to Capital|Long-Term Debt to Capital EXAS (Exact Sciences)|RVTY: Long-Term Debt to Capital Ratio|Bio-Rad - Long-Term Debt to Capital|NNNN - Long-Term Debt to Capital|Sterigenics (SHC) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio QDEL|OPK (OPKO Health, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital CareDx Corp|Long-Term Debt to Equity Maravai LifeSciences Holdings, Inc. (MRVI)|Long-Term Debt to Equity FLGT (Fulgent Genetics Inc)|Fluidigm - Long-Term Debt to Equity Ratio|Cytek Corp (CTKB) - Long-Term Liabilities to Capital|OSUR - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Exagen Inc. XGN|MDXH: Long-Term Debt to Capital|LUCD - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Prenetics Global Limited|Insight Molecular (IMDX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital TRIB|Long-Term Debt to Capital prophaselabs.com (PRPH)|Long-Term Debt to Capital CODX (Co-Diagnostics)|Ratio of Long-Term Indebtedness to Capital Heart Test Laboratories, Inc. (HSCS)|BMRA - Long-Term Debt to Equity|CDIO (Cardio Diagnostics) - Long-Term Debt to Capital Ratio|Virax Biolabs Group (VRAX) - Long-Term Debt to Equity|Long-Term Liabilities to Capital bluejaydx.com (BJDX)|Long-Term Debt to Equity Aspira Women's Health Inc.|Accelerate Diagnostics Inc. (AXDX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio CNTG (CENTOGENE, N.V.)|ENZ (enzo.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital FRES (Fresh2 Group)|Ratio of Long-Term Indebtedness to Capital Genetic Technologies Ltd (GENE)|ME - Long-Term Debt to Equity|PMD (Psychemedics Corp.) - Long-Term Debt to Capital Ratio